Candel Therapeutics Stock Market Value
| CADL Stock | USD 8.75 0.81 10.20% |
| Symbol | Candel |
Candel Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Candel Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Candel Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Candel Therapeutics.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Candel Therapeutics on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Candel Therapeutics or generate 0.0% return on investment in Candel Therapeutics over 90 days. Candel Therapeutics is related to or competes with Aerovate Therapeutics, Adagene, Acrivon Therapeutics,, Rezolute, AN2 Therapeutics, Molecular Partners, and Mineralys Therapeutics,. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for th... More
Candel Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Candel Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Candel Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.35 | |||
| Information Ratio | 0.124 | |||
| Maximum Drawdown | 99.24 | |||
| Value At Risk | (12.15) | |||
| Potential Upside | 16.62 |
Candel Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Candel Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Candel Therapeutics' standard deviation. In reality, there are many statistical measures that can use Candel Therapeutics historical prices to predict the future Candel Therapeutics' volatility.| Risk Adjusted Performance | 0.1109 | |||
| Jensen Alpha | 1.71 | |||
| Total Risk Alpha | 3.21 | |||
| Sortino Ratio | 0.1768 | |||
| Treynor Ratio | 0.9966 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Candel Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Candel Therapeutics Backtested Returns
Candel Therapeutics appears to be relatively risky, given 3 months investment horizon. Candel Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0913, which signifies that the company had a 0.0913 % return per unit of risk over the last 3 months. By analyzing Candel Therapeutics' technical indicators, you can evaluate if the expected return of 0.85% is justified by implied risk. Please makes use of Candel Therapeutics' Downside Deviation of 9.35, risk adjusted performance of 0.1109, and Mean Deviation of 7.29 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Candel Therapeutics holds a performance score of 7. The firm shows a Beta (market volatility) of 1.55, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Candel Therapeutics will likely underperform. Please check Candel Therapeutics' total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Candel Therapeutics' price patterns will revert.
Auto-correlation | 0.42 |
Average predictability
Candel Therapeutics has average predictability. Overlapping area represents the amount of predictability between Candel Therapeutics time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Candel Therapeutics price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Candel Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 1.39 |
Candel Therapeutics lagged returns against current returns
Autocorrelation, which is Candel Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Candel Therapeutics' stock expected returns. We can calculate the autocorrelation of Candel Therapeutics returns to help us make a trade decision. For example, suppose you find that Candel Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Candel Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Candel Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Candel Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Candel Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Candel Therapeutics Lagged Returns
When evaluating Candel Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Candel Therapeutics stock have on its future price. Candel Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Candel Therapeutics autocorrelation shows the relationship between Candel Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Candel Therapeutics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Candel Therapeutics Correlation, Candel Therapeutics Volatility and Candel Therapeutics Alpha and Beta module to complement your research on Candel Therapeutics. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Candel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.